- Home
- CJJD vs BIAF Comparison
CJJD vs BIAF Comparison
Compare CJJD & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJJD
- BIAF
- Stock Information
- Founded
- CJJD 2003
- BIAF 2014
- Country
- CJJD China
- BIAF United States
- Employees
- CJJD N/A
- BIAF N/A
- Industry
- CJJD Retail-Drug Stores and Proprietary Stores
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CJJD Consumer Staples
- BIAF Health Care
- Exchange
- CJJD Nasdaq
- BIAF Nasdaq
- Market Cap
- CJJD 12.4M
- BIAF 14.5M
- IPO Year
- CJJD N/A
- BIAF 2022
- Fundamental
- Price
- CJJD $1.82
- BIAF $1.04
- Analyst Decision
- CJJD
- BIAF Strong Buy
- Analyst Count
- CJJD 0
- BIAF 1
- Target Price
- CJJD N/A
- BIAF $6.00
- AVG Volume (30 Days)
- CJJD 5.9K
- BIAF 131.4K
- Earning Date
- CJJD 07-30-2024
- BIAF 11-14-2024
- Dividend Yield
- CJJD N/A
- BIAF N/A
- EPS Growth
- CJJD N/A
- BIAF N/A
- EPS
- CJJD N/A
- BIAF N/A
- Revenue
- CJJD $154,541,077.00
- BIAF $9,367,785.00
- Revenue This Year
- CJJD N/A
- BIAF $285.51
- Revenue Next Year
- CJJD N/A
- BIAF $20.05
- P/E Ratio
- CJJD N/A
- BIAF N/A
- Revenue Growth
- CJJD 3.85
- BIAF 2813.87
- 52 Week Low
- CJJD $1.34
- BIAF $0.83
- 52 Week High
- CJJD $4.80
- BIAF $3.62
- Technical
- Relative Strength Index (RSI)
- CJJD 39.36
- BIAF 42.08
- Support Level
- CJJD $1.78
- BIAF $0.83
- Resistance Level
- CJJD $1.93
- BIAF $1.04
- Average True Range (ATR)
- CJJD 0.10
- BIAF 0.11
- MACD
- CJJD -0.02
- BIAF 0.01
- Stochastic Oscillator
- CJJD 11.34
- BIAF 52.38
About CJJD China Jo-Jo Drugstores Inc. (Cayman Islands)
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.